PURCHASE ORDER
Active75F40126P00393
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$340K
obligated · signed 1 week ago
ONE (1) YEAR FIRM-FIXED-PRICE PURCHASE ORDER FOR PRECLINICAL ASSESSMENT OF NALOXONE ADEQUACY TO REVERSE POLYSUBSTANCE.
Performance timeline
Start
Sep 25, 2026
End
Sep 24, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 24, 2027
CHARLES RIVER LABORATORIES, INC.
Contract 75F40126P00393
UEI
NAPSK1UAMAE5
Parent Company
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 06
Current Obligation
$340,000
Base + Exercised Options
$340,000
Total Ceiling Value
$340,000
Contract Type
FIRM FIXED PRICE
NAICS
ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.